Related Experiment Video
Updated: Aug 23, 2025
Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods
Published on: December 21, 2019
In Silico Structural Analysis of Serine Carboxypeptidase Nf314, a Potential Drug Target in Naegleria fowleri
Pablo A Madero-Ayala1, Rosa E Mares-Alejandre1, Marco A Ramos-Ibarra1
1Biotechnology and Biosciences Research Group, Faculty of Chemical Sciences and Engineering, Autonomous University of Baja California, Tijuana 22390, Mexico.
Abstract:
Naegleria fowleri, also known as the "brain-eating" amoeba, is a free-living protozoan that resides in freshwater bodies. This pathogenic amoeba infects humans as a casual event when swimming in contaminated water. Upon inhalation, N. fowleri invades the central nervous system and causes primary amoebic meningoencephalitis (PAM), a rapidly progressive and often fatal disease. Although PAM is considered rare, reducing its case fatality rate compels the search for pathogen-specific proteins with a structure-function relationship that favors their application as targets for discovering new or improved drugs against N. fowleri infections. Herein, we report a computational approach to study the structural features of Nf314 (a serine carboxypeptidase that is a virulence-related protein in N. fowleri infections) and assess its potential as a drug target, using bioinformatics tools and in silico molecular docking experiments. Our findings suggest that Nf314 has a ligand binding site suitable for the structure-based design of specific inhibitors. This study represents a further step toward postulating a reliable therapeutic target to treat PAM with drugs specifically aimed at blocking the pathogen proliferation by inhibiting protein function.
Insights
Naegleria fowleri, or PAM, is a deadly brain infection. Researchers identified Nf314, a protein crucial for N. fowleri survival, as a potential drug target to combat this rare but fatal disease.
Area of Science:
- Infectious Diseases
- Parasitology
- Computational Biology
Background:
- Naegleria fowleri causes primary amoebic meningoencephalitis (PAM), a severe and often fatal CNS infection.
- PAM results from infection by the brain-eating amoeba, Naegleria fowleri, typically acquired through contaminated freshwater.
- Developing effective treatments for PAM is crucial due to its high case fatality rate.
Purpose of the Study:
- To investigate the structural characteristics of the Nf314 protein in Naegleria fowleri.
- To evaluate the potential of Nf314 as a therapeutic drug target for treating PAM.
- To explore structure-based drug design strategies against N. fowleri infections.
Main Methods:
- Utilized computational approaches, including bioinformatics tools.
- Performed in silico molecular docking experiments to study protein-ligand interactions.
- Analyzed the structural features and ligand binding site of the Nf314 protein.
Main Results:
- Identified Nf314, a serine carboxypeptidase, as a virulence-related protein in N. fowleri.
- The Nf314 protein possesses a suitable ligand binding site for inhibitor design.
- Computational analysis supports Nf314's potential as a specific drug target.
Conclusions:
- Nf314 is a promising therapeutic target for developing new drugs against Naegleria fowleri.
- Inhibiting Nf314 function could block pathogen proliferation and treat PAM.
- This study advances the development of targeted therapies for brain-eating amoeba infections.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
13:02Production, Crystallization, and Structure Determination of the IKK-binding Domain of NEMO
Published on: December 28, 2019